Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
January 1, 2007HeterocyclesOpen Access

Cardiovascular Agents: Renin Inhibitors and Factor Xa Inhibitors

View Full Paper
Ask AI
Bookmark
Share

Key result

Renin inhibitors and factor Xa inhibitors represent promising novel therapeutic approaches for the management of hypertension and thrombosis, respectively.

Design

Review

Authors

SMSamarendra N. MaitiNAEJA-RGM Pharmaceuticals (Canada)AKAparna KasaniRSRajendra SubediStatistics Canada

Discussion

Loading...

Member takes

Implication

Does not support practice change; leaves open efficacy in randomized trials for hypertension and thrombosis.

Structured PICO

I
Intervention
Renin inhibitors and Factor Xa inhibitors

This review highlights recent developments in renin inhibitors for hypertension and factor Xa inhibitors for anticoagulation.

Cite This Study

Maiti et al. (2007) conducted a review in Cardiovascular disease, hypertension, and thrombosis. Renin inhibitors and Factor Xa inhibitors was evaluated. Renin inhibitors and factor Xa inhibitors represent promising novel therapeutic approaches for the management of hypertension and thrombosis, respectively.

synapsesocial.com/papers/6a8f867dea0825e2ae1ec2e7https://doi.org/10.3987/rev-07-sr(u)1
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Structure-Based Design of Novel Guanidine/Benzamidine Mimics:  Potent and Orally Bioavailable Factor Xa Inhibitors as Novel Anticoagulants2003 · 96 citations
  2. 2Aliskiren, a novel, orally effective renin inhibitor, lowers blood pressure in marmosets and spontaneously hypertensive rats2005 · 157 citations
  3. 3Synthesis and Conformational Analysis of a Non-Amidine Factor Xa Inhibitor That Incorporates 5-Methyl-4,5,6,7-tetrahydrothiazolo[5,4-<i>c</i>]pyridine as S4 Binding Element2004 · 72 citations
  4. 4Synthesis and Evaluation of 1-Arylsulfonyl-3-piperazinone Derivatives as Factor Xa Inhibitors V. A Series of New Derivatives Containing a Spiro[imidazo[1,2-a]pyrazine-2(3H),4'-piperidin]-5(1H)-one Scaffold2006 · 9 citations
  5. 5Progress in the discovery of Factor Xa inhibitors2006 · 27 citations